secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2025-09-23T23:59:59+00:00
Accession:  0000927653-25-000125
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson raises FY2026 adj. EPS guidance to $38.05-$38.55; long-term growth target increased to 13%-16%
--------------------------------------------------------------------------------

- Fiscal 2026 Adjusted EPS guidance raised and narrowed to $38.05-$38.55 from $37.10-$37.90.
- Long-term Adjusted EPS growth target increased to 13%-16% from prior 12%-14%.
- New segment long-term growth targets: North American Pharmaceutical 5%-8%, Oncology & Multispecialty 13%-16%, Prescription Technology Solutions 10%-13%.
- Medical-Surgical separation and new organizational structure announced on Sept 18, 2025, reaffirmed at Investor Day.
- Investor Day webcast on Sept 23, 2025; Q2 FY2026 earnings scheduled for Nov 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000092765325000125/0000927653-25-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000092765325000125/mck-20250923.htm
  HTML page:      https://secwatch.observer/filing/0000927653-25-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer